Science & Enterprise subscription

Follow us on Twitter

  • A new book by David Warmflash, MD tells about interactions and experiences of humans with the moon, from legends an… https://t.co/GMGaQb5ipQ
    about 3 hours ago
  • New post on Science and Enterprise: Early Space Bio-Experiments Detailed in New Book https://t.co/MGKafYjKnw #Science #Business
    about 3 hours ago
  • A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications b… https://t.co/eMjzRJFxIZ
    about 4 hours ago
  • New post on Science and Enterprise: A.I. Chip Start-Up Raises $23M in Early Funds https://t.co/3YOa0YPC0r #Science #Business
    about 4 hours ago
  • A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable wi… https://t.co/g6t4Hg2kbR
    about 1 day ago

Please share Science & Enterprise

Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test

Brain scan (National Institute of Mental Health)

(National Institute of Mental Health)

Opko Health Inc., a biotechnology company in Miami, Florida, said today it has a collaboration agreement with the drug manufacturer Bristol-Myers Squibb Company for Opko’s diagnostic test technology. Opko’s blood tests are being developed from its technology that identifies biomarkers for a range of diseases including neurodegenerative disorders.

Part of the project calls for Opko and Bristol-Myers Squibb to investigate the potential for Opko’s technology to diagnose Alzheimer’s disease and identify individuals with early stage cognitive impairment that can progress to Alzheimer’s disease. The 7 January 2011 issue of the journal Cell has an article by Opko and academic researchers describing the technology that screens Immunoglobulin G (IgG) antibodies with arrays of synthetic molecules to find disease biomarkers.

The Palm Beach Post reports yesterday that the initial research was done by researchers at University of Texas Southwest Medical Center in Dallas and Scripps Research Institute in Jupiter, Florida. Opko Health licensed the technology for further development and commercialization.

Read More: Engineers Develop Biomarker Breathalyzer Diagnostics

*     *     *

Please share Science & Enterprise ...
error

2 comments to Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test